METABOLIC ASSOCIATED-DYSFUNCTION STEATOTIC LIVER DISEASE (MASLD)
Clinical trials for METABOLIC ASSOCIATED-DYSFUNCTION STEATOTIC LIVER DISEASE (MASLD) explained in plain language.
Never miss a new study
Get alerted when new METABOLIC ASSOCIATED-DYSFUNCTION STEATOTIC LIVER DISEASE (MASLD) trials appear
Sign up with your email to follow new studies for METABOLIC ASSOCIATED-DYSFUNCTION STEATOTIC LIVER DISEASE (MASLD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fasting diet shows promise for fatty liver disease
Disease control Recruiting nowThis study tests whether a 5:2 intermittent fasting diet (eating only about 600 calories on two days per week) can reduce liver fat in people with metabolic dysfunction-associated steatotic liver disease (MASLD). 120 adults with obesity and high liver fat will be randomly assigne…
Matched conditions: METABOLIC ASSOCIATED-DYSFUNCTION STEATOTIC LIVER DISEASE (MASLD)
Phase: NA • Sponsor: Universität des Saarlandes • Aim: Disease control
Last updated Jun 17, 2026 04:28 UTC
-
HIIT workouts may boost liver health in overweight adults
Disease control Recruiting nowThis study looks at whether high-intensity interval training (HIIT) can improve liver health in adults aged 18-59 who are overweight or have obesity and related conditions like diabetes. Thirty participants will either do HIIT for 8 weeks or continue their usual routine. The goal…
Matched conditions: METABOLIC ASSOCIATED-DYSFUNCTION STEATOTIC LIVER DISEASE (MASLD)
Phase: NA • Sponsor: Universidad San Sebastián • Aim: Disease control
Last updated Jun 01, 2026 18:03 UTC